Literature DB >> 14523122

Characterization of Enterococcus faecium mutants resistant to mundticin KS, a class IIa bacteriocin.

Youko Sakayori1, Mizuho Muramatsu, Satoshi Hanada, Yoichi Kamagata, Shinichi Kawamoto, Jun Shima.   

Abstract

The emergence and spread of mutants resistant to bacteriocins would threaten the safety of using bacteriocins as food preservatives. To determine the physiological characteristics of resistant mutants, mutants of Enterococcus faecium resistant to mundticin KS, a class IIa bacteriocin, were isolated. Two types of mutant were found that had different sensitivities to other antimicrobial agents such as nisin (class I) and kanamycin. Both mutants were resistant to mundticin KS even in the absence of Mg(2+) ions. The composition of unsaturated fatty acids in the resistant mutants was significantly increased in the presence of mundticin KS. The composition of the phospholipids in the two resistant mutants also differed from those in the wild-type strain. The putative zwitterionic amino-containing phospholipid in both mutants significantly increased, whereas amounts of phosphatidylglycerol and cardiolipin decreased. These changes in membrane structure may influence resistance of enterococci to class IIa and class I bacteriocins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523122     DOI: 10.1099/mic.0.26435-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  Physiological and Structural Differences Between Enterococcus faecalis JH2-2 and Mutant Strains Resistant to (P)-Divercin RV41.

Authors:  S Calvez; A Kohler; H Prévost; T Møretrø; D Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2010-12       Impact factor: 4.609

2.  Substantiation in Enterococcus faecalis of dose-dependent resistance and cross-resistance to pore-forming antimicrobial peptides by use of a polydiacetylene-based colorimetric assay.

Authors:  Jitender Mehla; S K Sood
Journal:  Appl Environ Microbiol       Date:  2010-11-29       Impact factor: 4.792

3.  Characterization of Class IIa Bacteriocin Resistance in Enterococcus faecium.

Authors:  Kathryn Geldart; Yiannis N Kaznessis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Bovicins: The Bacteriocins of Streptococci and Their Potential in Methane Mitigation.

Authors:  Anita Kumari Garsa; Prasanta Kumar Choudhury; Anil Kumar Puniya; Tejpal Dhewa; Ravinder Kumar Malik; Sudhir Kumar Tomar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

5.  Two interdependent mechanisms of antimicrobial activity allow for efficient killing in nylon-3-based polymeric mimics of innate immunity peptides.

Authors:  Michelle W Lee; Saswata Chakraborty; Nathan W Schmidt; Rajan Murgai; Samuel H Gellman; Gerard C L Wong
Journal:  Biochim Biophys Acta       Date:  2014-04-14

6.  Common Mechanism of Cross-Resistance Development in Pathogenic Bacteria Bacillus cereus Against Alamethicin and Pediocin Involves Alteration in Lipid Composition.

Authors:  Sunita Meena; Jitender Mehla; Raj Kumar; S K Sood
Journal:  Curr Microbiol       Date:  2016-07-05       Impact factor: 2.188

Review 7.  Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria.

Authors:  Soraya Omardien; Stanley Brul; Sebastian A J Zaat
Journal:  Front Cell Dev Biol       Date:  2016-10-14

8.  Complete genome sequences of two Enterococcus faecium strains and comparative genomic analysis.

Authors:  Yong-Qi Gan; Tao Zhang; Yong-Qiang Gan; Zhuang Zhao; Bin Zhu
Journal:  Exp Ther Med       Date:  2020-01-14       Impact factor: 2.447

9.  Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content.

Authors:  Nagendra N Mishra; Arnold S Bayer; Truc T Tran; Yousif Shamoo; Eugenia Mileykovskaya; William Dowhan; Ziqiang Guan; Cesar A Arias
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.